Location History:
- Ivoryton, CT (US) (1997)
- Groton, CT (US) (1998)
Company Filing History:
Years Active: 1997-1998
Title: Innovations of Burton Humphrey Jaynes: Pioneering Antibiotic Macrolides
Introduction
Burton Humphrey Jaynes is a notable inventor based in Ivoryton, CT, renowned for his contributions to the field of pharmaceutical innovations. With two registered patents to his name, Jaynes has made significant advancements in antibiotic research, particularly focusing on macrolide antibiotics.
Latest Patents
Jaynes' latest patents involve the development of antibiotic macrolides, specifically targeting derivatives of 16-membered ring 3-deoxy macrolide antibiotics such as rosaramicin and repromicin. These derivatives exhibit effectiveness against bacterial and mycoplasmic pathogens in animals, showcasing Jaynes' commitment to improving veterinary medicine. Furthermore, he has contributed to innovations concerning antibacterial 16-membered ring macrolides that contain olefins at the C-20 position, which further emphasize his expertise in antibiotic development.
Career Highlights
Burton Humphrey Jaynes is currently associated with Pfizer Corporation, a leading entity in the pharmaceutical industry known for its research and development in innovative healthcare solutions. His work at Pfizer has allowed him to leverage his understanding of macrolide antibiotics to develop products that hold the potential to save lives by combatting resistant pathogens.
Collaborations
Throughout his career, Jaynes has collaborated with distinguished professionals in the field, including colleagues Martin R. Jefson and Kristin M. Lundy. This teamwork has been instrumental in driving forward the progress of antibiotic research and enhancing the practical applications of their innovations.
Conclusion
In summary, Burton Humphrey Jaynes stands out as an influential inventor in the realm of antibiotic research. His latest patents not only reflect his innovative contributions to medicine but also underline the importance of collaboration in advancing scientific discovery. As a key figure at Pfizer Corporation, Jaynes continues to pave the way for new treatments that address critical health challenges in both humans and animals.